Ad
CLBS - Caladrius Biosciences Stock Trading
About | Caladrius Biosciences Inc. (NASDAQ:CLBS)
Not available
Quote | Caladrius Biosciences Inc. (NASDAQ:CLBS)
| Last: | $0.4264 |
|---|---|
| Change Percent: | -26.98% |
| Open: | $0.648 |
| Close: | $0.4264 |
| High: | $0.65 |
| Low: | $0.382 |
| Volume: | 26,625,149 |
| Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Caladrius Biosciences Inc. (NASDAQ:CLBS)
-
Caladrius Biosciences ( NASDAQ: CLBS ) announced that its stockholders approved all of the merger-related proposals by Caladrius and Cend Therapeutics, and the transactions contemplated thereby, including the Merger and the issuance of shares of Caladrius’ common stock ...
-
BASKING RIDGE, N.J., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), announced today that, based upon the final vote count certified by the independent inspector of elections for the annual meeting of ...
Message Board Posts | Caladrius Biosciences Inc. (NASDAQ:CLBS)
| Subject | By | Source | When |
|---|---|---|---|
| No posts yet. | |||
News, Short Squeeze, Breakout and More Instantly...
Caladrius Biosciences Inc. Company Name:
CLBS Stock Symbol:
NASDAQ Market:
Caladrius Biosciences Inc. Website:
Ad
-
BASKING RIDGE, N.J., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), announced today that, based upon the final vote count certified by the independent inspector of elections for the annual meeting of ...
-
NEW YORK, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the upcoming Life Sciences Virtual Investor Conference to be held on September 15 th . Individual investors, institutional ...
-
BASKING RIDGE, N.J., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company developing innovative therapies designed to treat or reverse disease, today announced tha...